Reece Restricted (REECF) This autumn 2026 Earnings Name Transcript


Reece Restricted (REECF) This autumn 2026 Earnings Name August 23, 2026 7:00 PM EDT

Firm Contributors

Peter Wilson – Chairman & CEO
Sasha Nikolic – MD, Group President & Govt Director
Andrew Younger – Chief Monetary Officer

Convention Name Contributors

Peter Steyn – Macquarie Analysis
Keith Chau – MST Monetary Providers Pty Restricted, Analysis Division
Lee Energy – JPMorgan Chase & Co, Analysis Division
Niraj-Samip Shah – Goldman Sachs Group, Inc., Analysis Division
Brook Campbell-Crawford – Barrenjoey Markets Pty Restricted, Analysis Division
Harry Saunders – E&P, Analysis Division
Daniel Sykes – Jarden Restricted, Analysis Division
Ramoun Lazar – Jefferies LLC, Analysis Division
Samuel Seow – Citigroup Inc., Analysis Division
Joseph Michael – Morgan Stanley, Analysis Division

Presentation

Operator

Good day, and thanks for standing by. Welcome to Reece Group Full 12 months 2026 Outcomes Convention Name. [Operator Instructions] Please be suggested that in the present day’s convention is being recorded.

I might now like handy the convention over to your first speaker in the present day, Mr. Peter Wilson, Chairman and Chief Govt Officer of Reece Group. Please go forward.

Peter Wilson
Chairman & CEO

Properly, good morning, everybody, and thanks for becoming a member of us for our FY ’26 outcomes name. Becoming a member of me in the present day are Sasha Nikolic and Andy Younger. And I’ll begin with an summary of the 12 months after which a recap of our technique; Sasha will then share how the enterprise is monitoring; Andy will then take you thru the financials earlier than I cowl the outlook and we open to questions. Earlier than we start, please notice all figures are in Australian {dollars}, except in any other case said.

Turning to an summary of FY ’26. We delivered gross sales income of $9.4 billion, which was up 4.5% on the prior 12 months. EBITDA was flat at $901 million, and EBIT was down 2.6% to $534 million. In ANZ, gross sales was up 8%, pushed by larger volumes with a 2% inflation contribution. Within the U.S., gross sales have been up 6.5%, pushed by community enlargement and in addition



Source link

Related articles

Ofqual urges ‘life-altering’ penalties for college students who use tech to cheat | Exams

College students in England may endure “life-altering” penalties if they're caught counting on AI or good glasses to cheat, England’s {qualifications} regulator has mentioned.The top of Ofqual, Ian Bauckham, mentioned college students might...

Technique Provides 485 Bitcoin as It Repurchases $228 Million of STRC Most well-liked Shares

TL;DR Technique disclosed a 485-BTC buy for roughly $33.4 million. Whole holdings reached 850,849 BTC on the reporting date. The identical announcement disclosed round $228 million of STRC repurchases, an vital financing element. Technique has added 485...

Do You Pay Taxes When You Promote Gold and Silver?

Overview When you plan on promoting your gold or silver, it is best to know the tax implications. The IRS classifies bodily gold and silver as collectibles, so the revenue on steel you held...

Polish Dealer XTB Has Worst Day Since 2021 as Polish Regulator Readies CFD Curbs

XTB's inventory fell 17.5% at present (Tuesday) after Poland's monetary regulator mentioned it will quickly limit the sale of contracts for distinction (CFDs). These merchandise generate many of the Warsaw-listed dealer's income.It was...

Royalty Pharma plc (RPRX) Presents at UBS International Biopharma Convention 2026 Transcript

Comply withPlay Earnings NamePlay Earnings Name Royalty Pharma plc (RPRX) UBS International Biopharma Convention 2026 November 17, 2026 5:40 AM EST Firm Individuals Christopher Hite - Chairman of Partnering & InvestmentsGreg...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com